LXP Industrial Trust (LXP) said late Monday it now expects 2026 adjusted funds from operations per diluted share of $3.30 to $3.40 from $3.22 to $3.37 earlier.
Analysts polled by FactSet expected $3.28.
In May, the company acquired a 37-acre infill industrial redevelopment site in the South Airport submarket of Phoenix for $103 million, according to a statement.
The site produces annual rent of $16.1 million, with 2% annual rent hikes, the company said.
Abivax SA (ABVX) said its Phase 3 maintenance trial evaluating obefazimod in adults with moderately to severely active ulcerative colitis met its primary endpointBoth the 25 mg and 50 mg doses also met all key secondary endpoints, including endoscopic improvement, endoscopic remission, corticosteroid-free clinical remission and sustained clinical remission, the company said Monday in a statement.Obefazimod demonstrated a favorable safety profile over the 44-week maintenance trial, with no new safety signals observed, the company said.Week-44 clinical remission rates were 50.8% with 25 mg and 51.3% with 50 mg, versus 10.4% for placebo, the company said.Abivax plans to submit a New Drug Application to the US Food and Drug Administration in Q4.Abivax shares fell 23% in after-hours trading.
Hewlett Packard Enterprise (HPE) reported fiscal Q2 adjusted earnings late Monday of $0.79 per diluted share, up from $0.38 a year earlier.Analysts polled by FactSet expected $0.53.Revenue in the three months ended April 30 rose to $10.7 billion from $7.63 billion a year earlier.Analysts surveyed by FactSet expected $9.78 billion.Hewlett Packard Enterprise expects Q3 adjusted EPS of $0.88 to $0.93 on revenue of $11.5 billion to $12.1 billion.Analysts polled by FactSet expect adjusted EPS of $0.58 on revenue of $10.9 billion.The company boosted full-year adjusted EPS guidance to $3.35 to $3.45 from the prior range of $2.30 to $2.50.Analysts polled by FactSet project $2.42.Hewlett Packard Enterprise shares surged 31% in after-hours trading.
Credo Technology (CRDO) reported fiscal Q4 adjusted earnings late Monday of $1.16 per diluted share, up from $0.35 a year earlier.Analysts polled by FactSet expected $1.02.Revenue in the three months ended May 2 rose to $437 million from $170 million a year earlier.Analysts surveyed by FactSet expected $431.8 million.The company expects Q1 revenue of $465 million to $475 million. Analysts expect $461.3 million.Credo shares fell 15% in after-hours trading.